Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, Follicular × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lymphoma 5 Lung Neoplasms 5 Multiple Myeloma 4 Lymphoma, Large-Cell, Anaplastic 4 Neuroblastoma 3 Neoplasms 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Neurofibromatosis 2 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

Rituximab 131 Cyclophosphamide 74 fludarabine phosphate 51 Whole-Body Irradiation 38 Peripheral Blood Stem Cell Transplantation 36 Mycophenolic Acid 36 Tacrolimus 32 Etoposide 28 Busulfan 28 Melphalan 24 Lenalidomide 23 Prednisone 22 Filgrastim 22 Cyclosporine 22 Bortezomib 22 Antilymphocyte Serum 21 Vincristine 19 Methotrexate 19 obinutuzumab 16 Bendamustine Hydrochloride 16 fludarabine 15 Doxorubicin 15 Radiotherapy 14 ibrutinib 13 Dexamethasone 13 Cytarabine 13 Cord Blood Stem Cell Transplantation 13 Carmustine 13 pembrolizumab 12 idelalisib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡